(S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells
- 31 March 2004
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 113 (3) , 503-510
- https://doi.org/10.1016/j.jaci.2003.12.039
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Inverse Correlation between (S)-Albuterol Levels and FEV1 in the Emergency DepartmentAcademic Emergency Medicine, 2002
- Levalbuterol and racemic albuterol: Are there therapeutic differences?Journal of Allergy and Clinical Immunology, 2001
- The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patientsJournal of Allergy and Clinical Immunology, 2001
- 858 Cytokine, chemokine, and nitric oxide (NO) release in stimulated small airway epithelial cells (SAEC) treated with ?2-agonist enantiomers of albuterolJournal of Allergy and Clinical Immunology, 2000
- The asthma-like pharmacology and toxicology of (S)-isomers of β agonists☆☆☆Journal of Allergy and Clinical Immunology, 1999
- Human Phosphoinositide 3-Kinase C2β, the Role of Calcium and the C2 Domain in Enzyme ActivityJournal of Biological Chemistry, 1998
- Heterogeneity in β-Adrenergic Receptor Kinase Expression in the Lung Accounts for Cell-specific Desensitization of the β2-Adrenergic ReceptorPublished by Elsevier ,1997
- Functional antagonism: tolerance produced by inhaled beta 2 agonists.Thorax, 1996
- Exacerbation of Airway Hyperreactivity by (±)Salbutamol in Sensitized Guinea PigsThe Japanese Journal of Pharmacology, 1993
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992